Olga Barreiro (Boston, United States)
While pursuing my PhD at the Immunology Unit in Hospital de la Princesa (Spain), the Weizmann Institute (Israel), the San Raffaele DIBIT (Italy) and the University of California Irvine (CA), I acquired a strong background in vascular biology and cell biology of the immune system as well as deep knowledge in a wide variety of imaging techniques, including spectroscopy and analytical microscopy. During that period of my career, I became more interested in the interaction between the immune and the vascular systems. Such fascination fueled my decision to start a postdoctoral training at the National Center of Cardiovascular Research, (Spain). Then, I was able to expand my knowledge on the innate immunity in the skin, by discovering a novel tissue-resident myeloid subset that interacts with the vasculature and possess a key role in wound healing.
In 2014, I joined Dr. von Andrian’s lab at the Microbiology and Immunobiology Department of Harvard Medical School. My purpose was to enlarge my expertise on microscopy, due to the extensive experience of this lab in multiphoton intravital microscopy (MP-IVM). Here, I have been applying this technique to disentangle the complex relationships among the peripheral sensory nervous system, the dermal microvasculature and the skin immune cells that govern many physiopathological contexts. Currently, my main ongoing project is focused on the study of a novel process of intravascular immune surveillance exerted by effector and memory CD8+ T lymphocytes to fight against acute viral infections in the dermal microvasculature.
David E. Fisher (Boston, United States)
David Fisher is chairman of Dermatology and director of the Melanoma Programme at Massachusetts General Hospital, Harvard Medical School. He is an expert in molecular oncology with particular emphasis on the biology of melanocytes and their involvement in malignant melanoma. He earned his Ph.D. from Rockefeller University with Drs. Henry Kunkel and Gunter Blobel, and his M.D. was obtained at Cornell University. He is also a graduate of the Curtis Institute of Music (cello). Dr. Fisher carried out residency training in internal medicine at Massachusetts General Hospital as well as clinical fellowships in both adult and paediatric oncology at Dana-Farber Cancer Institute and Boston Children’s Hospital. He conducted postdoctoral research in the lab of Nobel Laureate Phillip Sharp at the Massachusetts Institute of Technology. Dr. Fisher’s lab has carried out seminal research on melanocyte development, signaling, and transcription. He has discovered several human oncogenes, generated a reagent used worldwide for melanoma diagnosis, and serves as Principal Investigator for a Harvard-wide Program Project Grant in Melanoma. He has also studied novel skin cancer prevention strategies based upon models of redhead/fair-skinned high risk susceptibility and non-mutagenic tanning. Dr. Fisher has published >250 scholarly articles, many in the highest profile journals, and is former President of the Society for Melanoma Research and Chair of the Scientific Advisory Committee of the Melanoma Research Foundation.
Rick Guidotti (United States)
Rick Guidotti, an award-winning photographer, has spent the past eighteen years collaborating internationally with advocacy organisations/NGOs, medical schools, universities and other educational institutions to effect a sea-change in societal attitudes towards individuals living with genetic, physical, behavioral or intellectual difference. His work has been published in newspapers, magazines and journals as diverse as Elle, GQ, People, the American Journal of Medical Genetics, The Lancet, Spirituality and Health, the Washington Post, Atlantic Monthly and LIFE Magazine. Rick Guidotti is the founder and director of Positive Exposure.
Kenji Kabashima (Kyoto, Japan)
Kenji Kabashima graduated from Kyoto University in 1996. He trained in Medicine/Dermatology at the United Naval Hospital, Kyoto University Hospital, and University of Washington Medical Center. He started research on lipid mediators in immunology at Kyoto University, which led to a PhD (Prof. Shuh Narumiya). Then he studied at the Department of Dermatology, Kyoto University Graduate School of Medicine (Prof. Yoshiki Miyachi), UCSF (Prof. Jason Cyster), and University of Occupational and Environmental Health (Prof. Yoshiki Tokura). Currently, he is a chair/professor in the Department of Dermatology, Kyoto University Graduate School of Medicine, Japan, and a principal investigator at the IMB/SIgN, Singapore. His main interests include the mechanism of inflammatory skin diseases by gene-targeted mice and visualisation of the skin. His hobbies are jogging (personal record: 2:58:15 @Beppu Oita Marathon), climbing, and travelling.
Dan Lipsker (Strasbourg, France)
Dan Lipsker is Professor of Dermatology at the University of Strasbourg, France and he works as Dermatologist in the Clinique Dermatologique des Hôpitaux Universitaires de Strasbourg. He is interested in the whole spectrum of clinical dermatology. He has senior editing activities in dermatology and internal medicine Journals and has written and/or edited numerous books, among which the major French Textbook of Dermatology and a textbook on Clinical Examination in Dermatology.
He has worked and published in many fields, and his main interests include:
– diagnostic reasoning and morphologic approach to skin diseases;
– lyme borreliosis;
– skin manifestations of internal diseases;
– autoinflammatory diseases and the Schnitzler syndrome;
– melanoma epidemiology.
He has very strong interest in Lupus Erythematosus and he follows a huge number of patients with both the cutaneous and the systemic variant of the disease. He has coordinated as lead editor a multidisciplinary textbook on the topic. He has significantly contributed to a better knowledge of skin manifestations in patients with Lupus Erythematosus. He has suggested a new classification of skin lesions in patients with Lupus Erythematosus in 2010, that he will address during his topic.
Ralf Paus (Manchester, United Kingdom)
Ralf Paus, MD, FRSB, studied medicine in Würzburg, Vienna and Berlin, worked as house office at the University hospitals of Basel and Zurich (1986), and received his MD degree at the Free University Berlin, Germany (1987). He became fascinated by hair research during his time as post-doctoral research fellow at Yale University, New Haven, CT (1987-90), and has made this his main research focus ever since. After his dermatology residency and a junior faculty position in Berlin (Charité), he became Professor & Vice Chair in the Dept. of Dermatology, University Hospital Hamburg-Eppendorf (1999-2004) and worked as visiting Professor at the Max-Planck-Institute for Biochemistry, Munich-Martinsried (2005) before his appointment as Professor and Head of Experimental Dermatology at the University of Lübeck, Germany (2005-2013) and as Head of the Laboratory for Hair Research & Regenerative Medicine at the University of Münster, Germany (2013-2016). Since 2008, he has also been the Professor of Cutaneous Medicine at the University of Manchester, UK, where he has served as Director of Research & Deputy Lead of the Centre for Dermatology Research School of Biological Sciences since 2014. He has been Editor of Experimental Dermatology since 2007 and recently founded a skin & hair research company in his hometown, Münster (www.monasteriumlab.com).
Josef Penninger (Vienna, Austria)
Josef Penninger was formerly a lead researcher at the Amgen Research Institute in Toronto. In 2002 he accepted the appointment as founding director of the newly established Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna, Austria. Major achievements include pioneering insights into the molecular basis of osteoporosis and breast cancer, as well as the study of metastatic spread. His group has also developed the first haploid embryonic stem cells for functional genetics. He has authored and co-authored more than 580 scientific papers. Josef Penninger’s major awards include the Descartes Prize, the Wittgenstein Prize of the Austrian Federal Government, the Ernst Jung Prize for medical excellence, an AAAS Award the Innovator Award from Era of Hope/DOD and a second ERC Advanced grant.
Lidia Rudnicka (Warsaw, Poland)
Prof. Lidia Rudnicka is president of the Polish Dermatological Society, president of the International Trichoscopy Society, associate editor of the JEADV, chairman of the Poster Exhibit Task Force of the American Academy of Dermatology, member of the AAD Scientific Assembly Committee and Chairman of The Department of Dermatology, Medical University of Warsaw, Poland.
Throughout her live, she lived for several years in Chicago (USA), Berlin (Germany), Cologne (Germany), Philadelphia (USA) and Warsaw (Poland). Her professional pathway included graduation from the University of Cologne (Germany) and Medical University of Warsaw (Poland), fellowships at the Food and Drug Administration, USA (with Stephen I. Katz), Jefferson Medical College, USA (with Jouni Uitto), and University of Liege, Belgium (Charles Maurice Lapiere). Her first dermatology teacher and mentor was the famous Stefania Jablonska.
The scientific and clinical interests of Prof. Lidia Rudnicka are focused on two main topics: systemic sclerosis and hair disorders.
Her early work was related to the role of natural killer cells and adhesion molecules in systemic sclerosis. She is also the author of the hypothesis linking etiology of systemic sclerosis to a mutation in the topoisomerase I gene and abnormal topoisomerase I gene expression in lymphocytes.
Her second major field of activity is related to hair and scalp disorders. She made a major contribution to development hair and scalp dermoscopy and was the first to coin the term “trichoscopy”. In 2017 she founded together with Antonella Tosti, Rodrigo Pirmez and Daniel Asz Sigall the International Trichoscopy Society and was elected the first president of this society.